KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amneal Pharmaceuticals (AMRX) Other Non Operating Income (2017 - 2025)

Amneal Pharmaceuticals has reported Other Non Operating Income over the past 9 years, most recently at -$31.4 million for Q3 2025.

  • Quarterly results put Other Non Operating Income at -$31.4 million for Q3 2025, down 2762.56% from a year ago — trailing twelve months through Dec 2025 was -$25.5 million (down 365.49% YoY), and the annual figure for FY2025 was -$31.4 million, changed.
  • Other Non Operating Income for Q3 2025 was -$31.4 million at Amneal Pharmaceuticals, down from $1.6 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for AMRX hit a ceiling of $5.7 million in Q3 2022 and a floor of -$40.2 million in Q4 2023.
  • Median Other Non Operating Income over the past 5 years was $1.4 million (2024), compared with a mean of -$2.9 million.
  • Biggest five-year swings in Other Non Operating Income: soared 1140.56% in 2022 and later tumbled 2762.56% in 2025.
  • Amneal Pharmaceuticals' Other Non Operating Income stood at -$355000.0 in 2021, then soared by 1140.56% to $3.7 million in 2022, then tumbled by 1187.93% to -$40.2 million in 2023, then surged by 102.93% to $1.2 million in 2024, then tumbled by 2762.56% to -$31.4 million in 2025.
  • The last three reported values for Other Non Operating Income were -$31.4 million (Q3 2025), $1.6 million (Q2 2025), and $4.2 million (Q1 2025) per Business Quant data.